Vimarsana
Biggest News Aggregation in the World

Inducement Grant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inducement Grant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inducement Grant Today - Breaking & Trending Today

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule - Vimarsana News

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule

EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (

Viridian Therapeutics Appoints Jennifer Tousignant as Chief Legal Officer - Vimarsana News

Viridian Therapeutics Appoints Jennifer Tousignant as Chief Legal Officer

Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced the appointment of...

Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer - Vimarsana News

Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer

REDWOOD CITY, Calif., Jan. 24, 2024 -- Rezolute, Inc. , a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare...

Arvinas Appoints Jared Freedberg as General Counsel - Vimarsana News

Arvinas Appoints Jared Freedberg as General Counsel

Awards Mr. Freedberg an Inducement Grant in accordance with Nasdaq Listing Rule 5635NEW HAVEN, Conn., Jan. 16, 2024 -- Arvinas, Inc. , a clinical-stage biotechnology company creating a new class of...

Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference - Vimarsana News

Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference

- VRDN-001 topline clinical results for THRIVE and THRIVE-2 on track for mid-2024 and year-end 2024 in patients with active and chronic thyroid eye disease , respectively - - Subcutaneous VRDN-003...